title: Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
authors.forename: M
authors.initials: M
authors.lastname: McMorran
authors.forename: D
authors.initials: D
authors.lastname: Vu
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D017093:Liver Failure / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D000077154:Rosiglitazone; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones
chemical_list: D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone